Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001771498-26-000005

Chief Executive Officer gave up 12,306 shares (to pay taxes)

  • Chief Executive Officer acquired 28,296 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shea Jacqueline Elizabeth · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-20 Exercise or conversion : show line 1 in the form +28,296 123,327 D
2026-05-20 Shares withheld for taxes : show line 2 in the form −12,306 $1.23 $15,136 111,021 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-05-20 Exercise or conversion : show line 3 in the form Restricted Stock Unit −28,296 56,592 D
2026-05-20 Grant or award : show line 4 in the form Common Stock Option +123,760 123,760 D
2026-05-20 Grant or award : show line 5 in the form Restricted Stock Unit +100,240 100,240 D
Loading xslF345X06/wk-form4_1779393839.xml…